| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 6e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.085 | 0.09 |